paxilline has been researched along with erucylphospho-n,n,n-trimethylpropylammonium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aumailley, M; Cappuccini, F; Chometon, G; Jendrossek, V; Raducanu, A | 1 |
1 other study(ies) available for paxilline and erucylphospho-n,n,n-trimethylpropylammonium
Article | Year |
---|---|
The membrane-targeted alkylphosphocholine erufosine interferes with survival signals from the extracellular matrix.
Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Survival; Collagen Type I; Extracellular Matrix; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioblastoma; Humans; Integrin beta1; Male; Mice; Organophosphates; Paxillin; Phosphorylation; Prostatic Neoplasms; Quaternary Ammonium Compounds | 2014 |